 |
Hyaluronic Acid
Bouliga
3913900090
Bouliga
Fine line, Derm line, Deep line, Deeper line
1ml 2ml 5ml 10ml
20mg/ml
| Size: | |
|---|---|
High Viscosity HA Filler for Facial represents a premium solution for structural facial augmentation and deep wrinkle correction, offering exceptional lifting capacity and contouring precision. This specialized formulation features an ultra-high viscosity profile engineered to provide robust support for facial structures, making it ideal for cheek augmentation, jawline definition, and correction of deep facial folds. Unlike standard viscosity fillers that focus on volume alone, this high viscosity formulation delivers both lift and longevity for comprehensive facial rejuvenation.
Developed with advanced crosslinking technology, the filler maintains its structural integrity in high-movement facial areas while allowing natural expression. The unique rheological properties enable precise placement and sculpting, giving practitioners exceptional control over treatment outcomes. Clinical data confirms that this high viscosity formulation provides 30% greater lifting capacity compared to medium viscosity fillers, with aesthetic results maintained for 12–18 months in most patients. Its versatility makes it suitable for both youthful patients seeking preventive augmentation and mature patients addressing age-related volume loss.
With a viscosity rating of 336–406 Pa·s (measured via rheometry flow sweep analysis), the filler maintains shape integrity while allowing controlled placement. This high viscosity enables immediate lifting effect and resistance to deformation from facial movements, ensuring consistent results in dynamic areas like the lower face.
Featuring a 9% BDDE crosslinking ratio, the highest in its class, the formulation creates a resilient three-dimensional matrix that resists enzymatic degradation. This structure prolongs longevity in the face while maintaining the flexibility needed for natural facial expressions.
The filler combines 300–500μm particles in a cohesive gel matrix, providing both structural support and tissue integration. This particle size optimizes the balance between lift capacity and natural feel, avoiding the "artificial" texture associated with some high viscosity fillers.
A proprietary modification to the HA molecules enhances binding to collagen fibers in the dermis, reducing migration risk by 65% compared to conventional high viscosity fillers. This anchoring effect ensures stable results even in high-movement facial regions.
Conduct a thorough facial structural analysis, identifying areas requiring lifting versus volumization. Use the zygomatic arch to mandible line as a key reference for cheek augmentation planning. Mark injection points prior to treatment, typically in the deep malar, pre-auricular, and jawline regions.
Administer using a 25G needle or 23G micro-cannula with deep supraperiosteal placement for maximum lifting effect. Employ the fanning technique for cheek augmentation, delivering 0.3–0.5ml per pass and massaging gently to distribute product evenly. Total treatment volume typically ranges from 1–3ml per session, depending on anatomical needs.
For optimal results, apply in two layers: a foundational layer along bone structure (70% of volume) for lift, followed by a sculpting layer in the subcutaneous plane (30% of volume) for contour refinement. Allow 5 minutes between layers for product settling before assessing symmetry.
Advise patients to avoid excessive facial manipulation for 7 days and strenuous exercise for 48 hours. Sleep in an elevated position for the first 3 nights to minimize swelling. Schedule a follow-up appointment at 4 weeks to assess integration and perform any necessary adjustments.
It excels at structural augmentation including cheekbone enhancement, jawline definition, chin projection, and deep nasolabial fold correction. Its lifting capacity makes it particularly effective for midface rejuvenation and lower face contouring.
While the filler has greater thickness, it contains 0.3% lidocaine for patient comfort. Most patients report similar discomfort levels to standard fillers, with pain scores averaging 2.5/10 on clinical assessment scales.
The higher viscosity provides superior lifting capacity and longevity, making it suitable for structural augmentation rather than superficial wrinkle correction. It maintains shape better in high-movement areas but requires deeper placement for optimal results.
Yes, when placed correctly in deep tissue planes, it provides structural support without creating visible irregularities. Practitioners should use conservative volumes (0.5–1ml initially) for patients with thin dermis to ensure natural results.
Most patients experience mild swelling and possible bruising for 3–5 days. Significant social downtime is uncommon, with 85% of patients returning to normal activities within 48 hours. Applying arnica cream can help reduce bruising appearance.
High Viscosity HA Filler for Facial represents a premium solution for structural facial augmentation and deep wrinkle correction, offering exceptional lifting capacity and contouring precision. This specialized formulation features an ultra-high viscosity profile engineered to provide robust support for facial structures, making it ideal for cheek augmentation, jawline definition, and correction of deep facial folds. Unlike standard viscosity fillers that focus on volume alone, this high viscosity formulation delivers both lift and longevity for comprehensive facial rejuvenation.
Developed with advanced crosslinking technology, the filler maintains its structural integrity in high-movement facial areas while allowing natural expression. The unique rheological properties enable precise placement and sculpting, giving practitioners exceptional control over treatment outcomes. Clinical data confirms that this high viscosity formulation provides 30% greater lifting capacity compared to medium viscosity fillers, with aesthetic results maintained for 12–18 months in most patients. Its versatility makes it suitable for both youthful patients seeking preventive augmentation and mature patients addressing age-related volume loss.
With a viscosity rating of 336–406 Pa·s (measured via rheometry flow sweep analysis), the filler maintains shape integrity while allowing controlled placement. This high viscosity enables immediate lifting effect and resistance to deformation from facial movements, ensuring consistent results in dynamic areas like the lower face.
Featuring a 9% BDDE crosslinking ratio, the highest in its class, the formulation creates a resilient three-dimensional matrix that resists enzymatic degradation. This structure prolongs longevity in the face while maintaining the flexibility needed for natural facial expressions.
The filler combines 300–500μm particles in a cohesive gel matrix, providing both structural support and tissue integration. This particle size optimizes the balance between lift capacity and natural feel, avoiding the "artificial" texture associated with some high viscosity fillers.
A proprietary modification to the HA molecules enhances binding to collagen fibers in the dermis, reducing migration risk by 65% compared to conventional high viscosity fillers. This anchoring effect ensures stable results even in high-movement facial regions.
Conduct a thorough facial structural analysis, identifying areas requiring lifting versus volumization. Use the zygomatic arch to mandible line as a key reference for cheek augmentation planning. Mark injection points prior to treatment, typically in the deep malar, pre-auricular, and jawline regions.
Administer using a 25G needle or 23G micro-cannula with deep supraperiosteal placement for maximum lifting effect. Employ the fanning technique for cheek augmentation, delivering 0.3–0.5ml per pass and massaging gently to distribute product evenly. Total treatment volume typically ranges from 1–3ml per session, depending on anatomical needs.
For optimal results, apply in two layers: a foundational layer along bone structure (70% of volume) for lift, followed by a sculpting layer in the subcutaneous plane (30% of volume) for contour refinement. Allow 5 minutes between layers for product settling before assessing symmetry.
Advise patients to avoid excessive facial manipulation for 7 days and strenuous exercise for 48 hours. Sleep in an elevated position for the first 3 nights to minimize swelling. Schedule a follow-up appointment at 4 weeks to assess integration and perform any necessary adjustments.
It excels at structural augmentation including cheekbone enhancement, jawline definition, chin projection, and deep nasolabial fold correction. Its lifting capacity makes it particularly effective for midface rejuvenation and lower face contouring.
While the filler has greater thickness, it contains 0.3% lidocaine for patient comfort. Most patients report similar discomfort levels to standard fillers, with pain scores averaging 2.5/10 on clinical assessment scales.
The higher viscosity provides superior lifting capacity and longevity, making it suitable for structural augmentation rather than superficial wrinkle correction. It maintains shape better in high-movement areas but requires deeper placement for optimal results.
Yes, when placed correctly in deep tissue planes, it provides structural support without creating visible irregularities. Practitioners should use conservative volumes (0.5–1ml initially) for patients with thin dermis to ensure natural results.
Most patients experience mild swelling and possible bruising for 3–5 days. Significant social downtime is uncommon, with 85% of patients returning to normal activities within 48 hours. Applying arnica cream can help reduce bruising appearance.
